Roche Diagnostics announced the introduction of the Roche Cardiac 200. The instrument is a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments. The Roche Cardiac 200 is a lateral flow immunoassay testing system intended to provide quantitative cardiac marker test results on whole blood samples within 10 to 19 minutes. Physicians treating patients who present to the emergency department cannot afford to wait for testing methods, which can take longer than 60 minutes.
In an hour, the company’s Roche Cardiac 200 is able to process up to 36 tests. It offers a complete cardiac marker menu which includes NT-proBNP, Troponin I (TnI), CKMB and Myoglobin. The instrument makes use of an internal corrected fluorescence measurement technology to deliver reliability and accuracy which are consistent with the performance expectations of laboratory systems as defined by the National Academy of Clinical Biochemistry (NACB). Study results revealed that Roche Cardiac 200 diagnostic results for NT-proBNP and Troponin I are essentially equivalent to core lab results shows studies. The Roche Cardiac 200 offers flexible modular configurations and an easy-to-read touch screen to enable labs to address specific work flow needs. It also uses a internal standard which eliminates the need for routine recalibration.